SEC 13F Intelligence

Managers / Q4 2024 · view latest →

GENERAL ATLANTIC, L.P.

CIK 0001017645 · 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK, NY, 10055 · 212 715 4000

Reported Value
$2.8B
Q4 2024
Positions
16
Filings on Record
30
2019–present window
Filed
Feb 7, 2025
original filing

Summary

General Atlantic, L.P. reported $2.8B in U.S.-listed holdings across 16 positions for Q4 2024.

The portfolio is heavily concentrated: Dlocal alone accounts for 25.6% of reported value.

Compared with Q3 2024, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+7.3%
vs prior filed quarter
Top-10 Concentration
+97.0%
share of reported value
Largest Position
+25.6%
Dlocal

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.0BQ4 ’18Q1 ’19: $1.2BQ2 ’19: $1.7BQ3 ’19: $1.5BQ4 ’19: $3.7BQ4 ’19Q1 ’20: $2.3BQ2 ’20: $3.3BQ3 ’20: $6.5BQ4 ’20: $7.7BQ4 ’20Q1 ’21: $8.5BQ2 ’21: $14.1BQ3 ’21: $17.1BQ4 ’21: $13.0BQ4 ’21Q1 ’22: $10.9BQ2 ’22: $7.7BQ3 ’22: $8.5BQ4 ’22: $7.6BQ4 ’22Q1 ’23: $8.6BQ2 ’23: $6.3BQ3 ’23: $6.5BQ4 ’23: $7.0BQ4 ’23Q1 ’24: $4.3BQ2 ’24: $3.2BQ3 ’24: $3.5BQ4 ’24: $2.8BQ4 ’24Q1 ’25: $3.0BQ2 ’25: $3.6BQ3 ’25: $3.3BQ4 ’25: $2.9BQ4 ’25Q1 ’26: $2.1Bfilingsflow.com

Portfolio Composition

By security type
Other: 47.0%Common Stock: 45.6%ADR: 7.4%
  • Other · 47.0% · $1.3B
  • Common Stock · 45.6% · $1.3B
  • ADR · 7.4% · $207M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ADAGADAGENEADDED+3.56M3.83M+$7M$8M
GROVGROVE COLLABORATIVEADDED+1.54M2.47M+$2M$3M
8DTSQUARESPACESOLD OUT−10.61M0−$493M$0
BLNDBLEND LABSSOLD OUT−19.13M0−$72M$0
ALKTALKAMITRIMMED−5.88M9.65M−$136M$354M
THIRD HARMONIC BIOADDED+413.6K3.37M−$5M$35M
ACELYRINTRIMMED−194.3K2.70M−$6M$8M
DLOCALHELD+063.91M+$208M$720M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

16 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DLOCALCL A25.61%$720M63.91M
2ALHCALIGNMENT HEALTHCAREhistory →COM24.43%$686M60.99M
3ALKTALKAMIhistory →COM12.59%$354M9.65M
4XP, INCCL A12.49%$351M29.62M
5260CENTESSA PHARMACEUTICALShistory →ADS5.77%$162M9.68M
6AKROAKERO THERAPEUTICShistory →COM5.18%$146M5.23M
7PHARVARISCOM5.14%$144M7.53M
8EWCZEUROPEAN WAX CENTERhistory →CL A3.11%$87M13.11M
9ROYALTY PHARMACL A1.36%$38M1.50M
10IMCRIMMUNOCOREhistory →ADS1.32%$37M1.26M
11THIRD HARMONIC BIOCOM1.24%$35M3.37M
12RISKIFIEDCL A0.90%$25M5.32M
13ACELYRINCOM0.30%$8M2.70M
14ADAGADAGENEADS0.27%$8M3.83M
15WISHCL A0.15%$4M609.6K
16GROVGROVE COLLABORATIVECL A0.12%$3M2.47M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$2.1B12May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$2.9B13Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$3.3B16Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$3.6B15Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$3.0B15May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.8B16Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024$3.5B18Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$3.2B19Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$4.3B22May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$7.0B26Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$6.5B29Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$6.3B30Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$8.6B31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$7.6B33Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$8.5B39Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$7.7B38Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$10.9B35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$13.0B32Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$17.1B25Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$14.1B17Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$8.5B12May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$7.7B9Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$6.5B7Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B7Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.3B9May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.7B8Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.5B7Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.7B8Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.2B5May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.0B6Feb 11, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.